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Abstract
The prevailing viewpoint on children with rare trisomy conditions
such as trisomy 18 (t18) and trisomy 13 (t13) is almost uniformly
negative. Yet, case studies offer information about long-term
survivors. What is missing in the discussion is an unbiased
examination of surviving children within the context of necessary,
rather than “aggressive”, medical interventions and overall quality
of life. A move beyond palliative or comfort care must be an option
for this population. There must be a move toward valuation of
life and corresponding provision of treatment and examination of
developmental gains rather than limited intervention or palliative
care for infants with lethal fetal abnormalities. This article presents
a call to examine the individual child rather than decision making by
diagnosis framed by recommendations from the Convention on the
Rights of the Child (CRC) and Convention on the Rights of Persons
with Disabilities (CRPD) Medical professionals and parents must
work together to ensure medical needs are met and a positive
quality of life can be achieved.
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The prevailing viewpoint on children with rare trisomy conditions
such as trisomy 18 (t18) and trisomy 13 (t13) is almost uniformly
negative. Population based studies describe low survival rates for
infants commonly labeled as possessing “lethal fetal anomalies” or
who are considered “incompatible with life” [1-6]. Yet, case studies
are available highlighting long-term survival [7] as well as parents
sharing their experiences online via blogs and Facebook. The paradox
is clear. Studies describing large number of children are bleak
while individual cases are more positive. The majority of medical
professionals look to the former while parents the latter. This often
brings conflict when parents request medical interventions such
as surgery for their children [8,9]. An additional factor is a rise in
prenatal testing and diagnosis. Often, when t18 or t13 is confirmed,
parents receive recommendations for termination [10,11].
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What is missing in the current discussion is an unbiased
examination of surviving children within the context of necessary,
rather than “aggressive”, medical interventions and overall quality
of life. Writers in the areas of palliative care and bioethics largely
recommend limited medical intervention or only the provision of
comfort care for this population [12-16].
This author undertook a review of the current literature to
examine current perspectives on the topic. The parameters were
articles related to newborn palliative care in general and focused on
rare trisomy conditions and also key articles from the past decade
concerning fetal outcomes related to t18 and t13. Abstracts were then
reviewed to verify content. Author searches were also conducted.
Finally, recommendations from professional colleagues were sought.
Resulting articles and authors suggestions were followed up if not
already located with the above described methods. Key quotations
were also identified for inclusion in this article.

Current Perspectives
Little valuation of life is evidenced in the recommendations of
Goc et al. [14]. The authors do not recommend caesarean sections
or surgery in the immediate postnatal period for newborns with
t18. This is in the face of multiple reports such as those from Japan
of children living past the age of one year with positive surgical
outcomes [17-19]. In addition, at the present time, there is very little
literature on developmental outcomes [20,21]. This further impacts
and reinforces the prevailing view that focuses on a limited quality
of life and arguments against aggressive care [11-13,15]. There must
be a move toward valuation of life and corresponding provision of
treatment and examination of developmental gains rather than
limited intervention or palliative care for infants with “lethal” or
“severe” fetal abnormalities.
Concurrently, a significant article by Brown and Guralnick
[22] was published stating the importance of components of the
Convention on the Rights of the Child (CRC) and Convention on the
Rights of Persons with Disabilities (CRPD). For this article’s emphasis
on advocating for treatment of children with rare trisomy conditions,
several points are particularly significant including:
[Article 8: Raising awareness] emphasizes the importance of
addressing systemic discriminatory attitudes toward individuals with
disabilities, a reality that exists around the world. To that end, the
CRPD calls upon States Parties to raise awareness throughout society,
including within the family, regarding the rights of individuals with
disabilities in order ‘to combat stereotypes, prejudices and harmful
practices’ as well as to develop positive media campaigns and other
awareness programs (p. 278).
This is in marked contrast to much of the published work in
neonatal nursing and palliative care [8,23-25]. There is discussion of
induced abortion and feticide for infants with a severe fetal anomaly
such as t18 or t13. Chervanek and McCullough [26] explain “We
define ‘severe’ abnormalities as…compatible with survival in some
cases but result in virtual absence of cognitive function, e.g. trisomy
18…the potential for cognitive development – and therefore the
achievement of human and social goods, e.g. relationships with others
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– are virtually absent” (p. 255). It appears that the authors have not
reviewed the case studies or experienced contact with living infants
and children with t18 or t13. As this author can attest, cognition may
be significantly impaired but interactions and relationships with
parents, siblings and significant others (e.g., grandparents, teachers)
are evidenced in a variety of ways including eye contact, smiling,
laughing, reaching and vocalizing by children with these conditions.

to be developed, there is a necessity to gather more extensive data
(population-based and directly from parents and caregivers), build
consensus and, only then, offer recommendations. In fact, Janvier et
al. [31] describe positive perspectives from parents coupled with the
need to learn more about their experiences raising children with rare
trisomy conditions. Without these voices, there will be a continued
emphasis on comfort care and non-treatment.

Everett and Albersheim [27] describe Baby Smith, an infant with
t18. The authors describe a framework to “…increase transparency,
dialogue, understanding, and trust, which, in turn, may achieve
greater consensus” (p. 55) for medical care decision making. The
medical team refused to intubate Baby Smith and did not aggressively
treat his unspecified cardiac condition. The infant passed away on the
82nd day of life. What is most disheartening in this case study is the
lack of value placed on the infant’s life and his parents’ wishes for
more aggressive treatment. This is also evidenced in the care decisions
presented by Bruns and Crosier [28]. The infant, Simon, passed away
on the 88th day of life. As the case study indicates, quality of life is
only partially dependent on length and medical needs. The infant
encountered many difficulties during his brief life but all who came
into contact with him were positively affected including medical
professionals such as neonatal nurses and a pediatric cardiologist.
Their views on medical treatments changed as a result of caring for
Simon.

Offering a Positive Viewpoint and Associated
Recommendations

Interestingly, a study by Carey [29] of neonatologists’ views
on resuscitation of newborns with t18 states “It is critical that the
emphasis should remain on fostering the best interest of the infant
at every branch of the treatment decision tree” (p. 1109). Yet, this
positive outlook is tempered by the authors’ recommendation that
“Infants with lethal congenital anomalies and profound neurologic
impairment continue to have immense inherent worth as human
beings, and these infants are without doubt as deserving of love, care,
and dignity as any child”. However, we contend that having intensive
care measures such as intubation and corrective surgery available as
potential options for infants with a confirmed lethal trisomy gives
the impression to parents that these are reasonable interventions to
consider…” (p. 1108).
It is puzzling how both viewpoints can co-exist in terms of
identifying treatment options and reinforcing the notion of “lethal
congenital anomalies”. The authors offer some positive views on
decision making but reinforce the negative stance of many in the
palliative care field [9,12,15,16,27].
The literature reinforces the statistic of only 10% of affected
infants reaching their first birthday. This percentage is often cited
to parents at the time of prenatal diagnosis [2,6,13]. Yet, the 10%
amount does not grant the authors cited here exclusive emphasis on
the 90% of non-survivors. Investigations into differences between
long-term survivors and non-survivors are absent. There is a dearth
of information concerning characteristics of infants who die prior to
one month, for example, compared with those living between one and
three years. Analyses of these data are especially needed in the face of
recommendations for comfort care at birth and palliative care after
the immediate newborn period.
Koogler et al. [30] point out, parents should be presented with all
possible outcomes to arrive at informed decisions on their infant’s
behalf rather than being told their infant has a lethal anomaly and
should not receive care. In order for guidelines for decision making
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In this author’s experience, infants with t18 and t13 can and do
flourish after cardiac repair and similar types of aggressive medical
intervention [21,32]. Along with this data, there is a concomitant
need to examine the needs of individual children rather than overreliance on statistical information for decision making. Data collected
for the Tracking Rare Incidence Syndromes (TRIS) project includes
multiple data points on medical needs and services and developmental
outcomes. Two children in the TRIS database are described below:
Annabel was born in March 2005 at 40 weeks gestation via
planned c-section. She weighed 1986 grams. Medical issues at birth
included respiratory difficulties, heart murmur, ASD, VSD, feeding
difficulties and jaundice. She was diagnosed with trisomy 18, 11 days
after birth. Currently, Annabel’s most pressing issues are kidney and
liver functioning as well as related to feeding including PICC and
central line concerns. Annabel had ureteral replantation surgery
at 19 months. She currently receives medical care in the areas of
cardiology, dermatology, gastroenterology, genetics, ophthalmology,
pulmonology, and urology. Annabel imitates simple gestures.
Annabel associates names of objects with their representation. She
also displays preferences for familiar adults.
Arianna was born in June 2006 at 39 weeks gestation via vaginal
birth. She weighed 2781 grams. Medical issues at birth included
respiratory difficulties, ASD, PDA, VSD, feeding difficulties, and
jaundice. She was diagnosed at three days. Arianna required oxygen
until the spring of 2012. She is fed via a G-tube. She is also diagnosed
with hyperopia and conductive hearing loss. At seven months of
age, Arianna had cranial stenososis surgery. She also had her tonsils
and adenoids removed at 23 months. Arianna indicates preferences
for familiar adults and uses her hands to explore objects. She also
interacts during social games.
It is important to note that both children were diagnosed
postnatally. “Soft markers” were not identified for Annabel but
were present for Arianna. Her family did not consider termination
due to their religious beliefs. There is also much additional data on
both children describing educational and therapy services and use of
assistive items such as a gait trainer and augmentative communication
devices.
Most current literature does not provide this type of in-depth
discussion of long-term survivors and generally reinforces the
findings on early death or negative outcomes. Yet, this information
is needed to expand the current knowledge base for professionals
and provide parents with more positive, yet realistic (e.g., surgeries,
chronic conditions), outcomes. Annabel and Arianna’s famililes do
not focus on what their daughters cannot do or compare her to their
typically developing siblings. They celebrate their children for their
personality, temperament and abilities rather than their diagnosis.
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Lantos and Meadow [33] agree that decisions should be made
based on an individual infant’s response to treatment. Derrington and
Dworetz [34] also emphasize an individualized approach coupled with
understanding the values of each infant’s family. Information from
medical professionals is used to arrive at decisions regarding medical
interventions. Best interests of child re discussed with information
from physicians about possible outcomes. It is unfortunate that
the recommendations of Derrington and Dworetz [34] and Lantos
and Meadow [33] are not followed as evidenced by Thiele’s [35]
description of the circumstances she faced with her son with t18.
What makes this case particularly discouraging was the absence of
compassion after prenatal diagnosis of the condition. The author’s
account illustrates the medical profession’s bias toward a paradigm of
medical futility and placing minimal value on a life due to the child’s
rare trisomy diagnosis. With the continued rise of prenatal testing,
the end point of this perspective becomes increasingly disheartening.
Making treatment decisions in the best interests of an infant
cannot be effectively done with a “doom and gloom” orientation
as is often the case toward this population. How can hope be held
when a condition is characterized as “…lethal condition that [is] not
curable by intensive care…” [27]? How can parents make decisions
without counseling that incorporates a variety of outcomes and an
appreciation for quality of life [36-38]? Quality of life is not solely ours
to decide. It must be informed by all possible outcomes gleaned from
valid research including parent perspectives on their living as well as
deceased children. In this author’s experience with the TRIS project,
the latter group voices an almost uniform point of view of the value of
their child’s life regardless of how short, medical complications and
the like.
Merritt et al. [39] discuss decision making and the need for caseby-case review as the basis for decision-making rather than broad
recommendations. Nelson et al. [40] state “although diagnoses of
trisomy 13 and 18 are generally assumed to be fatal within days to
weeks after birth, a small but significant subgroup of children with
trisomy 13 and 18 are alive over the age of 1 year, and at least some
of these children receive substantial inpatient hospital care” (p. 874)
Yates et al. [41] point to a shift in interventions to address cardiac
anomalies based on parent request. Yet, the impact of these studies
is minimized by empirical reports emphasizing early mortality [42].
At the present time, there is no definitive consensus on medical
interventions and quality of life due to the reasons explained here.
A greater effort to collect longitudinal data is a starting point. The
TRIS project has up to six years of data for some children and adults
(project began in 2007; parents complete annual updates on medical
interventions, therapy services etc) There are no similar databases.
There continues to be a reliance on adherence to the “gloom and
doom” data cited in the literature [1,2,9,12,24,27] rather than a more
balanced representation of possible outcomes [17,19,29,36].

Conclusion
There is a need toward ethical case analysis for medical
interventions and determining quality of life for children with
t18 and t13 as described by Hentschel et al. [43]. The authors state
“more attention should be focused on the parents’ information
level and on their involvement in the decision-making process”
(p. 568). This perspective, along with data indicating the success of
medical interventions for this population [3,19,21,32,44,45] deserve
greater study and consideration. In addition, changing thoughts on
Volume 2 • Issue 1 • 1000103

palliative care must be considered on behalf of this population [46].
As Fenton [47] explained, “How easy it is to assume we know what
a good quality of life is for anyone other than ourselves. We assess
the burdens of care, the impact on siblings, the impact on parental
relationships, the impact on finances and the utilization of resources.
We perform ethical analyses assuming we truly understand how to
apply beneficence or maleficence to a child with trisomy 18 or 13 or
any other disorder in which there may be profound disability. As
if the child can tell us what he or she is feeling. But we can do our
best to assess and treat pain and discomfort. Smiles and laughter
need no score pad. We know what they mean. The advice we give
may often be centered around our personal notions about quality of
life… advocate for a willingness to do whatever it takes, however long
it takes, however many consults and team members it takes to fully
inform and understand the goals, values and aspirations parents may
have for their children. Once we have done that we need to honor
the parents by helping them achieve those goals whether it is comfort
care alone, a full court press or something in between.”
These along with directives established by the “…CRC and
CRPD…as the comprehensive articulation of the rights of all
individuals with disabilities including infants and young children”
discussed by Brown and Guralnick [22] and coupled with Carey’s [48]
recommendation for a “…balanced approach to counseling families
of the newborn with trisomy 18 and 13 at the time of diagnosis and
at decision points in management, that is, in the delivery room,
newborn nursery and clinic” are words to guide decision making.
The present review was intended to provide a counterpoint to
discussions of “incompatibility with life”, “lethal diagnoses” and
a general unwillingness for “aggressive” interventions. Long-term
survivors with rare trisomy conditions must be further studied so that
recommendations for their care can be made on an informed basis
rather than from a biased perspective inclined toward comfort care or
palliative care. Quality of life needs to enter the equation informed by
data and parent voices. Children like Annabel and Arianna deserve
no less.
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